We konden deze vermelding niet vinden. Er worden benaderende resultaten weergegeven. Controleer je spelling of stel voor deze term aan het woordenboek toe te voegen.
In many clinical trials the use of the full analysis set provides a conservative strategy.
多くの臨床試験において、最大の解析対象集団を用いることは保守的な戦略となる。
However, in an equivalence or non-inferiority trial use of the full analysis set is generally not conservative and its role should be considered very carefully.
When the full analysis set of subjects is used, violations of the protocol that occur after randomisation may have an impact on the data and conclusions, particularly if their occurrence is related to treatment assignment.
In confirmatory trials it is usually appropriate to plan to conduct both an analysis of the full analysis set and a per protocol analysis, so that any differences between them can be the subject of explicit discussion and interpretation.
All reasons for exclusion from analysis should be documented; for any subject included in the full analysis set but not in the per protocol set, the reasons for exclusion from the latter should also be documented.
Special problems arise in connection with subjects withdrawn from treatment after receiving one or more doses who provide no data after this point, and subjects otherwise lost to follow-up, because failure to include these subjects in the full analysis set may seriously undermine the approach.
Other methods employed to ensure the availability of measurements of primary variables for every subject in the full analysis set may require some assumptions about the subjects' outcomes or a simpler choice of outcome (e.g. success/ failure).
The full analysis set and the per protocol set play different roles in superiority trials (which seek to show the investigational product to be superior), and in equivalence or non-inferiority trials (which seek to show the investigational product to be comparable, see section 3.3.2).
When the full analysis set and the per protocol set lead to essentially the same conclusions, confidence in the trial results is increased, bearing in mind, however, that the need to exclude a substantial proportion of subjects from the per protocol analysis throws some doubt on the overall validity of the trial.
Under many circumstances it may also provide estimates of treatment effects which are more likely to mirror those observed in subsequent practice. There are a limited number of circumstances that might lead to excluding randomised subjects from the full analysis set including the failure to satisfy major entry criteria (eligibility violations), the failure to take at least one dose of trial medication and the lack of any data post randomisation.
If this is the 'full analysis set', estimates of the effect size may need to be reduced compared to the per protocol set (see Glossary). This is to allow for the dilution of the treatment effect arising from the inclusion of data from patients who have withdrawn from treatment or whose compliance is poor.
In superiority trials the full analysis set is used in the primary analysis (apart from exceptional circumstances) because it tends to avoid over-optimistic estimates of efficacy resulting from a per protocol analysis, since the non-compliers included in the full analysis set will generally diminish the estimated treatment effect.
Er worden alleen voorbeelden gegeven om u te helpen het woord of de woordcombinatie waarop u hebt gezocht, te vertalen. Deze worden niet door ons geselecteerd of gevalideerd en kunnen ongepaste taal bevatten. Wij vragen u melding te maken van voorbeelden die dienen te worden aangepast of verwijderd. Vertalingen met grof of informeel taalgebruik worden meestal rood of oranje gemarkeerd.